SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer

BACKGROUND: Fluorouracil (FU)-based chemotherapy regimens are indispensable in the comprehensive treatment of colorectal cancer (CRC). However, the heterogeneity of treated individuals and the severe adverse effects of chemotherapy results in limited overall benefit. METHODS: Firstly, Weighted gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Siyuan, Liu, Zaoqu, Ren, Xiaofeng, Xu, Hui, Ge, Xiaoyong, Ren, Yuqing, Zhang, Yuyuan, Dang, Qin, Liu, Long, Guo, Chunguang, Beatson, Richard, Deng, Jinhai, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283651/
https://www.ncbi.nlm.nih.gov/pubmed/35844556
http://dx.doi.org/10.3389/fimmu.2022.873871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283651/
https://www.ncbi.nlm.nih.gov/pubmed/35844556
http://dx.doi.org/10.3389/fimmu.2022.873871

Ejemplares similares